Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutland

Showing results (541-550 of 646) with videos related to

Pageof 65
Sort By:
Human Molecular Genetics|June 1, 1995
Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndromeM Oldridge, A O Wilkie, S F Slaney, et al.
Discover Oncology|July 19, 2025
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesisRichard Maliye, Shari Babu, Anna E Harris, et al.
Frontiers in Medicine|May 30, 2024
Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)Bruce K Patterson, Ram Yogendra, Jose Guevara-Coto, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locusL J Pulleyn, W Reardon, D Wilkes, et al.
Nature Genetics|February 1, 1995
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndromeA O Wilkie, S F Slaney, M Oldridge, et al.
Journal of Cell Science|August 8, 2025
Urinary renal epithelial cells for NPHP1 phenotyping and personalized therapeutic responsePraveen Dhondurao Sudhindar, Eric Olinger, Zachary T Sentell, et al.
Human Molecular Genetics|May 25, 2026
Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuriaDominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.
Jac-Antimicrobial Resistance|May 8, 2024
Influencing attitudes towards antimicrobial use and resistance in companion animals-the impact on pet owners of a short animation in a randomized controlled trialEmma Wright, Lisbeth Rem Jessen, Alice Tompson, et al.
International Journal of Molecular Sciences|January 23, 2024
p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer PatientsLi Ching Ooi, Vincent Ho, Jing Zhou Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2023
Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expressionNehal M Atallah, Maria Haque, Cecily Quinn, et al.
Pageof 65

Showing results (541-550 of 646) with videos related to

Sort By:
Pageof 65
Human Molecular Genetics|June 1, 1995
Mutations in the third immunoglobulin domain of the fibroblast growth factor receptor-2 gene in Crouzon syndromeM Oldridge, A O Wilkie, S F Slaney, et al.
Discover Oncology|July 19, 2025
Evaluation of human papillomavirus as a risk factor in prostate cancer pathogenesisRichard Maliye, Shari Babu, Anna E Harris, et al.
Frontiers in Medicine|May 30, 2024
Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)Bruce K Patterson, Ram Yogendra, Jose Guevara-Coto, et al.
European Journal of Human Genetics : EJHG|January 1, 1996
Spectrum of craniosynostosis phenotypes associated with novel mutations at the fibroblast growth factor receptor 2 locusL J Pulleyn, W Reardon, D Wilkes, et al.
Nature Genetics|February 1, 1995
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndromeA O Wilkie, S F Slaney, M Oldridge, et al.
Journal of Cell Science|August 8, 2025
Urinary renal epithelial cells for NPHP1 phenotyping and personalized therapeutic responsePraveen Dhondurao Sudhindar, Eric Olinger, Zachary T Sentell, et al.
Human Molecular Genetics|May 25, 2026
Specific knockout of kidney homogentisate 1,2-dioxygenase reveals that local metabolism of tyrosine and homogentisic acid is negligible in alkaptonuriaDominic A Rutland, Brendan P Norman, Juliette H Hughes, et al.
Jac-Antimicrobial Resistance|May 8, 2024
Influencing attitudes towards antimicrobial use and resistance in companion animals-the impact on pet owners of a short animation in a randomized controlled trialEmma Wright, Lisbeth Rem Jessen, Alice Tompson, et al.
International Journal of Molecular Sciences|January 23, 2024
p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer PatientsLi Ching Ooi, Vincent Ho, Jing Zhou Zhu, et al.
European Journal of Cancer (Oxford, England : 1990)|October 28, 2023
Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expressionNehal M Atallah, Maria Haque, Cecily Quinn, et al.
Pageof 65